Company Active LTD

Company profile

Intellegens Limited

Intellegens. Deep learning on sparse data in materials design and drug discovery

Intellegens Limited is a UK company with status active founded in 2017 based in East of England.

CRN
10591395
Founded
2017
Age
9

Overview

Legal name
INTELLEGENS LIMITED
Region
East of England
Registered address
LEWIS HOUSE
GREAT CHESTERFORD COURT
GREAT CHESTERFORD
ESSEX
UNITED KINGDOM
CB10 1PF
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
14 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

28 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

30 Jan
2017

Incorporated

Inception

Company registered at Companies House

Public funding

12 awards
First funded
2017
Funded years
2017, 2018, 2019, 2020, 2021, 2023, 2024
Age at first award
0 years

Projects

2024 EU-Funded Lead participant

RESTORE Sustainable Remanufacturing solution with increased automation and recycled content in laser and plasmabased process.

1 Jan 2024 to 31 Dec 2027

Awarded
£129,036
Total cost £129,036

In the pursuit of a Circular Economy, RESTORE seeks to revolutionize remanufacturing practices by introducing sustainable processes, materials, and digital tools. The project addresses the challenges of remanufacturing implementation by developing advanced cladding technologies, zero-waste materials, and a comprehensive digital platform. On the process fr...

2023 Collaborative R&D

IntelliJeni: The Future of 3D Printing Automation

1 Nov 2023 to 30 Nov 2024

Awarded
£54,318
Total cost £108,636

In the LEAD (Low Energy Autonomous Digital) Factory project, a consortium of world-leading companies joined forces to innovate and develop a ground-breaking automation system. The process involves creating functional plastics from plant waste, converting them into usable, eco-friendly polymers. This clean, low-energy manufacturing process is entirely cont...

2023 Collaborative R&D

HePSO AI

1 Aug 2023 to 31 Jan 2024

Awarded
£24,234
Total cost £24,234

This is a collaborative project undertaken by ICAX and Intellegens to study the application of AI by machine learning into ICAX's product and service streams for the built environment. Areas of special interest have been identified by ICAX through their vast experience delivering innovative low carbon heating technologies for small- and large-scale constr...

2023 Collaborative R&D Lead participant

Intellegens: Developing a novel ML-driven tool to advance Oligonucleotide-therapeutic characterisation and manufacturing.

1 Jun 2023 to 31 May 2025

Awarded
£310,421
Total cost £443,458

Intellegens Ltd is seeking to develop a novel ML-powered digital tool to provide organisations with a user interface for oligonucleotide characterisation and impurity prediction. Intellegens will collaborate with the Centre for Process Innovation (CPI) to build an extensive database of associated structures and intelligent look-up logic defined and coded ...

2023 Collaborative R&D Lead participant

Accelerating adoption of AI in materials and chemicals to deliver net zero goals faster

1 May 2023 to 31 Jul 2023

Awarded
£48,901
Total cost £48,901

Intellegens seek support to create a consortium to accelerate the adoption and trustworthiness of artificial intelligence (AI) and machine learning (ML) technologies in the materials and chemicals industries in the UK. Intellegens is a provider of advanced machine learning software, Alchemite(tm), with an international network of existing customers, partn...

2021 Collaborative R&D

Accelerated Na-ion battery technology development through machine learning, advanced modelling and digitalisation for traceability (AccelerateSIB)

1 Sep 2021 to 28 Feb 2023

Awarded
£50,313
Total cost £71,876
2020 BIS-Funded Programmes Lead participant

Machine Learning for Additive Manufacturing Experimental Design Algorithm (MEDAL)

1 Dec 2020 to 30 Nov 2021

Awarded
£104,647
Total cost £209,294

MEDAL will develop a method of optimising process parameters by suggesting a minimum number of new experiments based on legacy data. This will significantly reduce process optimisation cost and time.

2020 Feasibility Studies Lead participant

Planning for a pandemic: a global disease modelling platform

1 Jun 2020 to 28 Feb 2021

Awarded
£48,916
Total cost £48,916

The COVID-19 pandemic poses significant difficulties for the UK. Headlines are full of stories of the shortage of critical supplies that whip up a political whirlwind: personal protective equipment, critical drugs for patients in intensive care, ventilators, and sufficient hospital staff. The problem extends beyond the COVID-19 pandemic, with the same iss...

2019 Collaborative R&D

Intelligent enterprise Data Management platform for BATtery manufacturing - IDMBAT (or HESTIA)

1 Sep 2019 to 28 Feb 2021

Awarded
£75,359
Total cost £107,656

Responding to the growing battery manufacturing market and significant technical challenges, IDMBAT will address a substantial gap in the market by developing software solutions for battery manufacturers to reduce fabrication and development costs while improving key batteries metrics. This will be achieved by combining the proven benefits of a systematic...

2019 Feasibility Studies

Chemeia: A synergistic AI integrated architecture for augmenting high value dark-data.

1 May 2019 to 31 Jan 2021

Awarded
£102,849
Total cost £146,927

"Data curation across scientific research and development (R&D) environments is a critical process for ensuring results from in-house experiments and external publications are effectively structured & integrated for further reuse, reinterpretation & reference. It supports a number of broad downstream activities associated with big data analytics, such as ...

2018 Collaborative R&D

A Next-Generation Platform for Novel Drug Discovery Using Deep Learning of ADMET Properties.

1 Sep 2018 to 31 Aug 2020

Awarded
£128,961
Total cost £184,229

Integrated through Optibrium's existing software offering (StarDrop(tm)), DeepADMET is a next-generation project that will develop and apply novel deep learning methods to extend and improve predictive models of important Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) endpoints to guide more efficient design and selection of high qua...

2017 Feasibility Studies Lead participant

Demonstrator for application of AI to experimental data.

1 Oct 2017 to 30 Sep 2018

Awarded
£43,155
Total cost £95,900

Intellegens, a provider of specialist Artificial Intelligence (AI) algorithms to the drug discovery and material design sectors, proposes an experimental development project to enable integration of its unique algorithms with specialist software and modelling pipelines. Intellegens’ algorithms are used to add insights to data, where large portions of data...

Product types

BIS-Funded Programmes Collaborative R&D EU-Funded Feasibility Studies